Lymphoma | Maryland Oncology Hematology Lymphoma – Maryland Oncology Hematology

Trial ID 20289 EDP Rockville

NCT04254107 ID
USOR ID: 20289 Phase I
A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects with Advanced Malignancies

Trial ID 18263 STAR

NCT04116437 ID
USOR ID: 18263 Phase II
A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated B-Cell Lymphoma Intolerant of Prior Treatment with Ibrutinib and/or Acalabrutinib 

Trial ID BGB-11417-201

NCT05471843 ID
Phase II

Trial ID RGX-104-001

NCT02922764 ID
Phase I

Quality Care Close to Home

View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology